Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Because of the potential adverse events and teratogenesis of antipsychotic drugs, it is important to find a safe and effective treatment for pregnant women with severe mental illness. The membrane hypothesis of schizophrenia provides a rationale to treat symptoms of schizophrenia with omega-3 PUFAs. We report a 30-year-old married woman with chronic schizophrenia, who experienced an episode of acute exacerbation of psychotic symptoms during pregnancy. After entering into an open trial of omega-3 PUFAs monotherapy, she showed a dramatic improvement in both positive and negative symptoms of schizophrenia and a significant increase of omega-3 PUFA composition in erythrocyte membrane. There were no adverse effects in this treatment. Thus, omega-3 PUFAs could be both beneficial and therapeutic to pregnant schizophrenic women.

Original languageEnglish
Pages (from-to)295-299
Number of pages5
JournalEuropean Neuropsychopharmacology
Volume11
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Omega-3 Fatty Acids
Schizophrenia
Pregnant Women
Teratogenesis
Erythrocyte Membrane
Antipsychotic Agents
Therapeutics
Pregnancy
Membranes

Keywords

  • Docosahexaenoic acid (DHA)
  • Ecosapentaenoic acid (EPA)
  • Omega-3 polyunsaturated fatty acids (PUFAs)
  • Pregnancy
  • Schizophrenia
  • Teratogenesis

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neurology
  • Pharmacology
  • Psychology(all)

Cite this

Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient. / Su, Kuan Pin; Shen, Winston W.; Huang, Shih Yi.

In: European Neuropsychopharmacology, Vol. 11, No. 4, 2001, p. 295-299.

Research output: Contribution to journalArticle

@article{29a5ddbcb6aa49b188a3d4c1c0c3b908,
title = "Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient",
abstract = "Because of the potential adverse events and teratogenesis of antipsychotic drugs, it is important to find a safe and effective treatment for pregnant women with severe mental illness. The membrane hypothesis of schizophrenia provides a rationale to treat symptoms of schizophrenia with omega-3 PUFAs. We report a 30-year-old married woman with chronic schizophrenia, who experienced an episode of acute exacerbation of psychotic symptoms during pregnancy. After entering into an open trial of omega-3 PUFAs monotherapy, she showed a dramatic improvement in both positive and negative symptoms of schizophrenia and a significant increase of omega-3 PUFA composition in erythrocyte membrane. There were no adverse effects in this treatment. Thus, omega-3 PUFAs could be both beneficial and therapeutic to pregnant schizophrenic women.",
keywords = "Docosahexaenoic acid (DHA), Ecosapentaenoic acid (EPA), Omega-3 polyunsaturated fatty acids (PUFAs), Pregnancy, Schizophrenia, Teratogenesis",
author = "Su, {Kuan Pin} and Shen, {Winston W.} and Huang, {Shih Yi}",
year = "2001",
doi = "10.1016/S0924-977X(01)00098-0",
language = "English",
volume = "11",
pages = "295--299",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient

AU - Su, Kuan Pin

AU - Shen, Winston W.

AU - Huang, Shih Yi

PY - 2001

Y1 - 2001

N2 - Because of the potential adverse events and teratogenesis of antipsychotic drugs, it is important to find a safe and effective treatment for pregnant women with severe mental illness. The membrane hypothesis of schizophrenia provides a rationale to treat symptoms of schizophrenia with omega-3 PUFAs. We report a 30-year-old married woman with chronic schizophrenia, who experienced an episode of acute exacerbation of psychotic symptoms during pregnancy. After entering into an open trial of omega-3 PUFAs monotherapy, she showed a dramatic improvement in both positive and negative symptoms of schizophrenia and a significant increase of omega-3 PUFA composition in erythrocyte membrane. There were no adverse effects in this treatment. Thus, omega-3 PUFAs could be both beneficial and therapeutic to pregnant schizophrenic women.

AB - Because of the potential adverse events and teratogenesis of antipsychotic drugs, it is important to find a safe and effective treatment for pregnant women with severe mental illness. The membrane hypothesis of schizophrenia provides a rationale to treat symptoms of schizophrenia with omega-3 PUFAs. We report a 30-year-old married woman with chronic schizophrenia, who experienced an episode of acute exacerbation of psychotic symptoms during pregnancy. After entering into an open trial of omega-3 PUFAs monotherapy, she showed a dramatic improvement in both positive and negative symptoms of schizophrenia and a significant increase of omega-3 PUFA composition in erythrocyte membrane. There were no adverse effects in this treatment. Thus, omega-3 PUFAs could be both beneficial and therapeutic to pregnant schizophrenic women.

KW - Docosahexaenoic acid (DHA)

KW - Ecosapentaenoic acid (EPA)

KW - Omega-3 polyunsaturated fatty acids (PUFAs)

KW - Pregnancy

KW - Schizophrenia

KW - Teratogenesis

UR - http://www.scopus.com/inward/record.url?scp=0034893932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034893932&partnerID=8YFLogxK

U2 - 10.1016/S0924-977X(01)00098-0

DO - 10.1016/S0924-977X(01)00098-0

M3 - Article

VL - 11

SP - 295

EP - 299

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 4

ER -